AGP Picks
View all

Biopharma automation market set to reach $3.16 billion by 2030

Nov. 4, 2026
Biopharma automation market set to reach $3.16 billion by 2030
By AI, Created 15:15 UTC, Nov 04, 2026, AGP -

The automation market in biopharma is projected to grow from $2.19 billion in 2025 to $2.35 billion in 2026, then climb to $3.16 billion by 2030, according to The Business Research Company. The report points to rising robot use, tighter regulatory demands and more complex biologic manufacturing as key drivers.

Why it matters: - Biopharma manufacturers are leaning harder on automation to improve output, reduce contamination risk and meet regulatory requirements as production gets more complex. - The market outlook points to sustained spending on robotics, digital systems and process control across drug manufacturing.

What happened: - The Business Research Company released its Global Market Report 2026 on automation in the biopharma industry. - The report estimates the market will grow from $2.19 billion in 2025 to $2.35 billion in 2026. - The report forecasts the market will reach $3.16 billion by 2030. - The company published both a free sample report and the full market report.

The details: - The report says the market grew in recent years because biologic drug manufacturing became more complex. - Other growth drivers include demand for scalable biopharma production, early adoption of laboratory automation, growth in contract manufacturing services and better process control technologies. - The report forecasts a 7.1% CAGR from 2025 to 2026. - It projects a 7.7% CAGR through 2030. - The report says future growth will come from investments in smart biomanufacturing plants, wider use of continuous manufacturing, expansion in personalized biologics production, compliance-focused automation and efficiency gains. - The report highlights future trends including robotic manufacturing systems, digital twin technology, automated quality control, end-to-end bioprocess automation and data-driven production management. - Automation in biopharma covers advanced technologies and robotics used across biopharmaceutical manufacturing to replace manual tasks and improve efficiency, accuracy and productivity.

Between the lines: - Robot adoption is becoming a central signal for how fast biopharma automation may scale. - The report points to a broader shift from task automation toward integrated, data-heavy manufacturing systems. - In September 2024, the International Federation of Robotics reported a 9% increase in industrial robot installations across Europe’s manufacturing sector, reaching 92,393 units. - The federation said 73,534 of those installations, or 80%, were in the European Union, up 2% from the prior year. - The geographic data suggests industrial automation momentum is broadening beyond biopharma into manufacturing more generally.

What's next: - North America held the largest share of the automation in biopharma industry market in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The Business Research Company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspot infographics, and updated technology and trend analysis. - The company also provided contact details for analysts and sales inquiries in the release.

The bottom line: - Biopharma automation is shifting from a niche efficiency upgrade to a core manufacturing strategy, with robots, software and compliance tools expected to drive the next phase of market growth.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Middle East Business Channel

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Middle East Business Channel

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.